Stocks and Investing
Stocks and Investing
Wed, March 1, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, February 28, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Daniel Grosslight Maintained (TDOC) at Hold with Decreased Target to $30 on, Feb 28th, 2023
Daniel Grosslight of Citigroup, Maintained "Teladoc Health, Inc." (TDOC) at Hold with Decreased Target from $33 to $30 on, Feb 28th, 2023.
Daniel has made no other calls on TDOC in the last 4 months.
There are 8 other peers that have a rating on TDOC. Out of the 8 peers that are also analyzing TDOC, 4 agree with Daniel's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- George Hill of "Deutsche Bank" Maintained at Hold with Decreased Target to $27 on, Monday, February 27th, 2023
- Lisa Gill of "JP Morgan" Maintained at Hold with Decreased Target to $33 on, Monday, February 27th, 2023
- Marc Solecitto of "Barclays" Maintained at Hold with Decreased Target to $28 on, Wednesday, January 18th, 2023
- Jonathan Yong of "Credit Suisse" Maintained at Hold with Decreased Target to $30 on, Monday, October 31st, 2022
These are the ratings of the 4 analyists that currently disagree with Daniel
- Michael Wiederhorn of "Oppenheimer" Maintained at Buy with Decreased Target to $35 on, Thursday, February 23rd, 2023
- Sean Dodge of "RBC Capital" Reiterated at Buy and Held Target at $35 on, Thursday, February 23rd, 2023
- Stephanie Davis of "SVB Leerink" Upgraded from Hold to Buy and Held Target at $34 on, Thursday, February 23rd, 2023
- Colin Rusch of "Oppenheimer" Maintained at Buy with Decreased Target to $37 on, Thursday, January 19th, 2023
Contributing Sources